3D Genome Mapping Reveals a Hidden Layer of Alzheimer's Pathology
核心洞察
A Science study found that the three-dimensional organization of the genome differs in brain cells of people with Alzheimer's disease (搜索) versus unaffected individuals.
Researchers combined single-cell GAGE-seq, spatial transcriptomics, and a new deep learning model called Hicformer to link genome folding with gene activity.
Alzheimer's cells showed 'increased compartment mingling,' more long-range and fewer short-range DNA contacts, and reduced overall gene activity.
Researchers have identified a previously underappreciated layer of Alzheimer's disease (搜索) biology: the three-dimensional organization of the genome. In a study published in Science, scientists found that in certain brain cells of Alzheimer's patients, the 3D architecture of DNA differs from that of unaffected individuals, linking genome folding to altered gene activity and tissue organization.
The work was led by Jian Ma, the Ray and Stephanie Lane Professor of Computational Biology at Carnegie Mellon University, with Hansruedi Mathys, assistant professor of neurobiology at the University of Pittsburgh School of Medicine, directing the Pitt arm of the study. Collaborating institutions included the Broad Institute of MIT and Harvard (搜索), the University of California, Los Angeles, the University of Washington, and the Rush Alzheimer's Disease Center (搜索). The research was supported by grants from the National Institutes of Health.
"Alzheimer's disease (搜索) cannot be understood one layer at a time," Ma said. "The genome's 3D structure is a fundamental regulatory layer that helps to connect DNA sequence to gene activity. By integrating genome folding, cell state, and tissue context, we can move beyond cataloging disease-associated changes toward understanding how they fit together and which mechanisms to test next."
Combining Single-Cell and Spatial Technologies
The team analyzed individual cells from postmortem brain tissue of Alzheimer's patients and unaffected people, examining samples from the prefrontal cortex. The tissue came from participants in a long-term dementia study who later donated their brains for research.
To build a detailed picture, the researchers combined several technologies. GAGE-seq measures both gene expression and three-dimensional genome contacts within the same individual cell. Spatial transcriptomics preserves information about where gene activity occurs within intact brain tissue. Together, these datasets allowed the scientists to connect the physical organization of the genome with gene regulation while observing where Alzheimer's-related molecular and cellular changes appeared in the surrounding tissue.
A newly developed deep learning model, Hicformer, was also central to the work. The artificial intelligence model combines DNA sequence information with broad patterns of genome folding and detailed maps of physical DNA contacts to predict gene activity across different cell types. Xinyue Lu, a doctoral student in computational biology who co-led the research, described the system as a computational test bed for exploring how changes in genome folding might alter gene activity.
"Measuring gene activity and genome folding in the same cell allows us to directly connect chromosome structure with disease-related gene programs," said Yang Zhang, a project scientist in the Computational Biology Department who co-led the research. "Across several kinds of brain cells, this paired view revealed a consistent signature of 3D genome reorganization in Alzheimer's disease (搜索) and helped us prioritize regulatory regions for future mechanistic and therapeutic investigation."
Compartment Mingling and Disrupted Gene Regulation
The researchers identified several consistent differences in genome architecture. Large sections of the genome are normally organized into relatively distinct active and inactive regions known as compartments. In Alzheimer's cells, those boundaries appeared less sharply defined — a pattern the paper terms "increased compartment mingling."
Several kinds of brain cells also showed fewer interactions between nearby sections of the genome and more contacts between regions located farther apart. Cells with greater compartment mingling tended to have lower overall levels of gene activity. The team additionally observed weaker interactions between genes and nearby regulatory elements that normally help control whether genes are switched on or off, while some contacts across intermediate distances became stronger.
These structural differences were associated with reduced activity in programs involved in neurons and synapses, along with changes in metabolism and cellular stress responses. The researchers also found links to senescence-related programs in microglia, the brain's immune cells that help maintain brain health and respond to damage.
"Our study represents a major advance in understanding what goes wrong in Alzheimer's disease (搜索)," Mathys said. "We know the classic hallmarks of Alzheimer's disease — accumulation of amyloid-beta plaques (搜索) and tau tangles (搜索) — but our results establish higher-order chromatin (搜索) alterations as a component of the molecular pathology associated with the disease, which currently affects seven million Americans, a number that continues to grow."
Toward New Therapeutic Targets
When the researchers mapped these molecular changes across intact brain tissue, they found that genome reorganization was connected not only to altered gene activity but also to differences in how brain cells were arranged within the tissue.
The results establish three-dimensional genome organization as another important layer of Alzheimer's disease (搜索) biology and provide a framework for testing which changes in genome architecture might directly contribute to the disease. Future studies can now investigate whether particular structural changes help drive Alzheimer's progression and whether any of the affected regulatory regions could eventually become targets for new therapies.
The authors emphasize that considerably more work will be needed before these findings translate into treatment changes. Nonetheless, the study positions 3D DNA organization as a crucial facet of Alzheimer's biology, opening a new frontier for research into the neurodegenerative disorder, which has been recognized since the early 1900s and whose first linked gene was identified in 1987.